A Randomized Controlled Trial of High-Dose Vitamin D2 Followed by Intranasal Insulin in Alzheimer's Disease
Mark S Stein, Samuel C Scherer, Kylie S Ladd, Leonard C Harrison
Journal of Alzheimer's Disease | IOS PRESS | Published : 2011
MrEric Huggins (Chairman), Dr Peter Habersberger (Medical Director) and Trustees of The Shepherd Foundation for generous funding and enthusiastic support; Dr Mal Eutick (Pharmalab) for advice on insulin diluent; Alex Kelly (Pharmalab), David Chadwick (Pharmatel Fresenius Kabi P/L) for preparation and packaging of diluent; Richard Oppenheim, Hung Truong (Cardinal Health) for capsule manufacture; Professor Serge Gaultier, McGill University for permission to use DAD; A/Prof Ian Gordon, Statistical Consulting Centre, University of Melbourne for randomization and statistical analyses; Lynn Mather, Alzheimer's Australia Victoria, Lynne Scott and Elizabeth Fraser for recruitment; Monika Meehan for pharmacy; Vee Lyn Tan, Susan Edwards, Zoe Ellis, Caroline Francis, Jennie Barnett, Bianca Dudfield and Shinay Mackey for occupational therapy; Kate Frencham and Lucy Smith for neuropsychological assessment; Rhiannon Jones and Karen Harris for administrative assistance; Maria Bisignano, Cecilia Hsieh, Max Goodwin and Maraed Harrop for biochemical analyses. LCH is National Health and Medical Research Council Australia Senior Principal Research Fellow and is funded by a Victorian State Government Operational Infrastructure Support Grant.